Telemedicine uses a variety of electronic communications media,ranging from teleconferencing to image-sharing to remote patient monitoring,to provide clinical services to a patient.As the American Telemedicine Association points ...
Tags: Telemedicine, electronic communications media, Healthcare CIOs
GI Dynamics has gained full approval to initiate ENDO trial for its non-surgical EndoBarrier device from the US Food and Drug Administration (FDA). The EndoBarrier liner, which is implanted into the gut, is a flexible, tube-shaped device ...
Tags: ENDO trial, non-surgical EndoBarrier device, EndoBarrier liner
The European Union has granted CE mark to C8 MediSensors' non-invasive continuous glucose monitor (nCGM), designed for use in patients with diabetes. The new portable system, Optical Glucose monitor measures glucose readings by the ...
Tags: non-invasive continuous glucose monitor, nCGM, Optical Glucose monitor
TAMARAC, Fla. -- City Furniture has opened an employee Health & Wellness Center at its company headquarters here, a new perk designed to help cut health-related expenses for both employees and the company. Keith Koenig, left, and Doreen ...
Tags: Furniture
Diabetes patients using Hypurin Porcine Isophane insulin cartridges have been urged to check their medication is correct by the Medicines and Healthcare products Regulatory Agency (MHRA) after a packaging error came to light The issue ...
Tags: diabetes patients, packaging error, carton for cartridges
US based Lincoln Financial Group has spun off Lincoln VisionConnect, a fully insured vision plan for employer benefit packages, which caters full range of vision benefits, assisting employees to improve quality of life and production of ...
Medi+Sure, a provider of diabetes devices, has announced that the Government of British Columbia (BC) has approved its 49c Medi+Sure blood glucose test strips. The approval allows Medi+Sure to provide its Medi+Sure blood glucose test ...
AbGenomics International, a biopharmaceutical company, has obtained FDA agreement on Its Phase 2 clinical trial plans of the novel autoimmune therapeutic candidate, AbGn-168H. The current Phase 2 AbGn-168H trial will be a multicenter, ...
Tags: FDA approval, psoriatic, clinical trial, pharmaceutical product
The US Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) of Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company for Tradjenta (linagliptin) tablets for use as add-on therapy to insulin. ...
Tags: FDA, sNDA, pharmaceutical product, clinical development
Genentech, a member of Roche Group, has obtained clearance for its Lucentis 0.3 mg (ranibizumab injection) from the US Food and Drug Administration (FDA). Lucentis 0.3 mg is a recombinant humanized monoclonal antibody fragment (lacking an ...
Tags: Genentech, Lucentis 0.3 mg, Medicine, Injection
The National Institutes of Health (NIH) has awarded two-year small business innovation research (SBIR) grant of $582,473 to Biodel to develop a concentrated ultra-rapid-acting insulin formulations for use in closed loop pump system, also ...
Boehringer Ingelheim and Eli Lilly and Company have received European Commission marketing authorization for Jentadueto (linagliptin/metformin hydrochloride) tablets. Jentadueto is a new, single-tablet treatment option, taken twice daily, ...
Tags: marketing authorization, Jentadueto tablets, glycemic control
Abbott has received CE mark approval for Architect HbA1c assay, designed to monitor treatment efficacy for diabetes patients. The chemiluminescent microparticle Architect HbA1c assay, which is designed for the quantitative determination ...
Tags: Architect HbA1c assay, Architect i immunoassay systems
GlaxoSmithKline (GSK) will pay $3bn, which includes a $1bn criminal fine and forfeiture and $2bn to resolve civil claims, in fine and will plead guilty for promoting antidepressants Paxil and Wellbutrin for unapproved uses. The largest ...
Tags: antidepressant, criminal fine, civil claim, health care fraud
Eli Lilly and Company has officially opened the Lilly China Research and Development Center (LCRDC), a diabetes-focused research and development center in Shanghai, China. The focus of LCRDC is on the discovery of new diabetes medicines ...
Tags: Eli Lilly and Company, China Research and Development Center, diabetes